Activity Details

Free CME
0.75 AMA PRA Category 1 Credit
Released: March 27, 2018
Expires: March 27, 2019
0.75 hour to complete

Jointly Provided By

Target Audience

Dermatology clinicians who manage patients with moderate-to-severe atopic dermatitis (AD)

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Apply current principles of pathophysiology of atopic dermatitis and the concept of atopic march to therapeutic approaches to disease management
  2. Develop treatment plans for patients with atopic dermatitis that reflect evidence-based guidelines, use of new therapeutic options, and strategies to optimize short-term control and long-term management of the disease
  3. Address quality-of-life issues and psychosocial comorbidities in managing patients with atopic dermatitis
  4. Utilize shared decision making and develop treatment plans that will result in high levels of adherence and better patient outcomes

Activity Description

Recent developments in the treatment of moderate-to-severe atopic dermatitis (AD) have changed the way in which we are able to manage the disease. This interactive case-based educational program allows you to meet 3 patients in an AD clinic, make management decisions, compare your responses with those of your peers, and learn from the experts about best management approaches.


Mark Lebwohl, MD (Chair)
Kimberly and Eric J. Waldman Professor of Dermatology
Icahn School of Medicine at Mount Sinai
Chairman, Kimberly and Eric J. Waldman Department of Dermatology
Mount Sinai Health System
New York, NY

Emma Guttman, MD, PhD
Professor of Dermatology, Sol and Clara Kest
Icahn School of Medicine at Mount Sinai
New York, NY

David M. Pariser, MD, FACP, FAAD
Professor of Dermatology
Eastern Virginia Medical School
Virginia Clinical Research
Pariser Dermatology Specialists
Norfolk, VA

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Mark Lebwohl, MD, is an employee of Mount Sinai which receives research funds from: Abbvie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Janssen/Johnson & Johnson, Kadmon, Medimmune/Astra Zeneca, Novartis, Pfizer, Valeant, and ViDac; Allergan, Aqua Leo-pharma, and Promius (Consultant)
  • Emma Guttman, MD, PhD, has affiliations with AbbVie, Allergan, Almirall, Amgen, Anacor, AnaptyBio, Asana Biosciences, BMS, Celgene, Curadim, Dermira, Eli Lilly, Escalier, Galderma, Glenmark, Kiowa Kirin, Kymab, LEO Pharmaceuticals, Medimmune, Novartis, Pfizer, Regeneron, Sanofi, Sienna, Theravance, and Vitae (Consultant)
  • David M. Pariser, MD, FACP, FAAD, has affiliations with Bickel Biotechnology, Biofrontera AG, Celegene, Dermira, DUSA Pharmaceuticals, LEO Pharmaceuticals, Novartis, Promius, Regeneron, Sanofi, TheraVida, and Valeant (Consultant); Pfizer (Advisory Board); Abbott Laboratories, Amgen, Asana Biosciences, Bickel Biotechnology, Celgene, Dermavant Sciences, Eli Lilly, LEO Pharmaceuticals, Merck, Novartis, Novo Nordisk, Ortho Dermatologics, Peplin, Photocure, Promius, Regeneron, Stiefel, and Valeant (Contracted Research).

RMEI Medical Education, LLC

  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
  • Misha Mutizwa, MD, has affiliations with Celgene (Consulting Fees).
  • Sharon Powell, has no affiliations with commercial interests to disclose.       

Postgraduate Institute for Medicine
The following PIM planners and managers: Judi Smelker-Mitchek, MBA, MSN, RN; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.

Joint Accreditation Statement

Accreditation Council for Pharmacy EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Receive Credit

By reviewing the course content and successfully completing the post-test and evaluation, physicians/DOs are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians/DOs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Commercial Support

This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Technical Support

For any technical issues or issues with your CME Certificate, please visit:

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.